General Dosage
250-500mg daily for general liver support
Maximum dose: 1750mg/day (used in clinical trials without serious adverse effects)
TUDCA (Tauroursodeoxycholic Acid) Dosage Guide
Evidence:Moderate
·
This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer
Dosage Recommendations
General recommendation: 250-500mg daily for general liver support
Timing: Take with meals, divided into 2-3 doses for higher dosages • Take with food for best absorption.
Dosage by Condition
General liver protection
250-500mg dailyModerate
Cholestatic liver disease
750-1500mg dailyStrong
Steroid/prohormone liver support
500-1000mg dailyEmerging
Metabolic/insulin resistance support
1500-1750mg dailyEmerging
| Condition | Recommended Dose | Evidence |
|---|---|---|
| General liver protection | 250-500mg daily | Moderate |
| Cholestatic liver disease | 750-1500mg daily | Strong |
| Steroid/prohormone liver support | 500-1000mg daily | Emerging |
| Metabolic/insulin resistance support | 1500-1750mg daily | Emerging |
Upper limit: 1750mg/day (used in clinical trials without serious adverse effects)
Timing & Absorption
Take with meals, divided into 2-3 doses for higher dosages
Best taken with food for optimal absorption.
Find a TUDCA (Tauroursodeoxycholic Acid) with the right dose
We verify actual dosage against clinical research
References
- RCTPan XL, Zhao L, Li L, Li AH, Ye J, Yang L, Xu KS, Hou XH (2013). Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: A double-blind randomized controlled trial. Journal of Huazhong University of Science and Technology - Medical Sciences. DOI PubMed
- ObservationalRodrigues CM, Fan G, Ma X, Kren BT, Steer CJ (1998). A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. Journal of Clinical Investigation. DOI PubMed
- RCTKars M, Yang L, Gregor MF, Mohammed BS, Pietka TA, Finck BN, Patterson BW, Horton JD, Mittendorfer B, Hotamisligil GS, Klein S (2010). Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes. DOI PubMed